Literature DB >> 9378814

The plasma cell associated antigen detectable by antibody VS38 is the p63 rough endoplasmic reticulum protein.

A H Banham1, H Turley, K Pulford, K Gatter, D Y Mason.   

Abstract

AIMS: To characterise the 64 kDa intracellular antigen present on normal and neoplastic plasma cells detected by monoclonal antibody VS38 and by another antibody, MC186, of similar reactivity.
METHODS: The VS38 monoclonal antibody was used to screen a bacterially expressed peripheral blood cDNA library, and the immunocytochemical staining of the two antibodies was compared with those raised specifically to the protein identified as the VS38 antigen.
RESULTS: A partial cDNA encoding the VS38 antigen was cloned and shown to be identical to the human p63 gene. p63 is a non-glycated, reversibly palmitoylated type II transmembrane protein which is found in rough endoplasmic reticulum. Antibody MC186 also recognised this protein and both VS38 and MC186 together with two antibodies raised to p63 gave identical immunostaining patterns.
CONCLUSIONS: The VS38 antigen was identified as the rough endoplasmic reticulum protein p63. While it is not exclusively expressed on plasma cells, the presence of p63 distinguishes plasma cells from other lymphoid cells because of their high secretory activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378814      PMCID: PMC499978          DOI: 10.1136/jcp.50.6.485

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Characterization of a monoclonal antibody having selective reactivity with normal and neoplastic plasma cells.

Authors:  A W Tong; J C Lee; M J Stone
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Immunophenotypic spectrum of plasma cell leukemia.

Authors:  M D Linden; A J Fishleder; R R Tubbs; H Park
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

4.  Antigens on human plasma cells identified by monoclonal antibodies.

Authors:  K C Anderson; E K Park; M P Bates; R C Leonard; R Hardy; S F Schlossman; L M Nadler
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

5.  Restriction of docking protein to the rough endoplasmic reticulum: immunocytochemical localization in rat liver.

Authors:  M Hortsch; G Griffiths; D I Meyer
Journal:  Eur J Cell Biol       Date:  1985-09       Impact factor: 4.492

6.  Immunochemical analysis of rough and smooth microsomes from rat liver. Segregation of docking protein in rough membranes.

Authors:  M Hortsch; D I Meyer
Journal:  Eur J Biochem       Date:  1985-08-01

7.  Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.

Authors:  P L Tazzari; M Gobbi; A Dinota; A Bontadini; G Grassi; C Cerato; M Cavo; S Pileri; F Caligaris-Cappio; S Tura
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

8.  An antigenic study of human plasma cells in normal tissue and in myeloma: identification of a novel plasma cell associated antigen.

Authors:  P D Nathan; L Walker; D Hardie; P Richardson; M Khan; G D Johnson; N R Ling
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

9.  Flow-cytometric detection of terminal deoxynucleotidyl transferase and other intracellular antigens in combination with membrane antigens in acute lymphatic leukemias.

Authors:  I C Slaper-Cortenbach; L G Admiraal; J M Kerr; E F van Leeuwen; A E von dem Borne; P A Tetteroo
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

10.  VS38 immunostaining in melanocytic lesions.

Authors:  J H Shanks; S S Banerjee
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

View more
  5 in total

1.  VS38 as a promising CD38 substitute antibody for flow cytometric detection of plasma cells in the daratumumab era.

Authors:  Shumpei Mizuta; Takahito Kawata; Hiroshi Kawabata; Noriko Yamane; Saya Mononobe; Takao Komai; Yusuke Koba; Naoya Ukyo; Akira Tamekane; Mitsumasa Watanabe
Journal:  Int J Hematol       Date:  2019-06-10       Impact factor: 2.490

Review 2.  Diffuse large B-cell lymphomas with plasmablastic differentiation.

Authors:  Julie Teruya-Feldstein
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

3.  Lymphocyte-specific protein 1: a specific marker of human leucocytes.

Authors:  K Pulford; M Jones; A H Banham; E Haralambieva; D Y Mason
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

4.  Utility of VS38c in the diagnostic and prognostic assessment of osteosarcoma and other bone tumours/tumour-like lesions.

Authors:  E S Hookway; Z Orosz; Y Uchihara; A Grigoriadis; A B Hassan; U Oppermann; N A Athanasou
Journal:  Clin Sarcoma Res       Date:  2017-09-18

5.  Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).

Authors:  L Sanoja-Flores; J Flores-Montero; J J Garcés; B Paiva; N Puig; A García-Mateo; O García-Sánchez; A Corral-Mateos; L Burgos; E Blanco; J Hernández-Martín; R Pontes; M Díez-Campelo; P Millacoy; P Rodríguez-Otero; F Prosper; J Merino; M B Vidriales; R García-Sanz; A Romero; L Palomera; R Ríos-Tamayo; M Pérez-Andrés; J F Blanco; M González; J J M van Dongen; B Durie; M V Mateos; J San-Miguel; A Orfao
Journal:  Blood Cancer J       Date:  2018-11-19       Impact factor: 11.037

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.